U.S. flag

An official website of the United States government

NM_001370259.2(MEN1):c.1328C>A (p.Ser443Tyr) AND Multiple endocrine neoplasia, type 1

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Jun 27, 2017
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000467767.8

Allele description [Variation Report for NM_001370259.2(MEN1):c.1328C>A (p.Ser443Tyr)]

NM_001370259.2(MEN1):c.1328C>A (p.Ser443Tyr)

Gene:
MEN1:menin 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
11q13.1
Genomic location:
Preferred name:
NM_001370259.2(MEN1):c.1328C>A (p.Ser443Tyr)
HGVS:
  • NC_000011.10:g.64805056G>T
  • NG_008929.1:g.11239C>A
  • NG_033040.1:g.3186C>A
  • NM_000244.4:c.1343C>A
  • NM_001370251.2:c.1454C>A
  • NM_001370259.2:c.1328C>AMANE SELECT
  • NM_001370260.2:c.1328C>A
  • NM_001370261.2:c.1328C>A
  • NM_001370262.2:c.1223C>A
  • NM_001370263.2:c.1223C>A
  • NM_130799.3:c.1328C>A
  • NM_130800.3:c.1343C>A
  • NM_130801.3:c.1343C>A
  • NM_130802.3:c.1343C>A
  • NM_130803.3:c.1343C>A
  • NM_130804.3:c.1343C>A
  • NP_000235.3:p.Ser448Tyr
  • NP_001357180.2:p.Ser485Tyr
  • NP_001357188.2:p.Ser443Tyr
  • NP_001357189.2:p.Ser443Tyr
  • NP_001357190.2:p.Ser443Tyr
  • NP_001357191.2:p.Ser408Tyr
  • NP_001357192.2:p.Ser408Tyr
  • NP_570711.1:p.Ser443Tyr
  • NP_570711.2:p.Ser443Tyr
  • NP_570712.2:p.Ser448Tyr
  • NP_570713.2:p.Ser448Tyr
  • NP_570714.2:p.Ser448Tyr
  • NP_570715.2:p.Ser448Tyr
  • NP_570716.2:p.Ser448Tyr
  • LRG_509t2:c.1328C>A
  • LRG_509:g.11239C>A
  • LRG_509p2:p.Ser443Tyr
  • NC_000011.9:g.64572528G>T
  • NM_130799.2:c.1328C>A
Protein change:
S408Y
Links:
dbSNP: rs1060499981
NCBI 1000 Genomes Browser:
rs1060499981
Molecular consequence:
  • NM_000244.4:c.1343C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001370251.2:c.1454C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001370259.2:c.1328C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001370260.2:c.1328C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001370261.2:c.1328C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001370262.2:c.1223C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001370263.2:c.1223C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_130799.3:c.1328C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_130800.3:c.1343C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_130801.3:c.1343C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_130802.3:c.1343C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_130803.3:c.1343C>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_130804.3:c.1343C>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Multiple endocrine neoplasia, type 1 (MEN1)
Synonyms:
MEA I; MEN I; Endocrine adenomatosis multiple; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0007540; MeSH: D018761; MedGen: C0025267; Orphanet: 652; OMIM: 131100

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000541213Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Jun 27, 2017)
germlineclinical testing

PubMed (5)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Menin missense mutants encoded by the MEN1 gene that are targeted to the proteasome: restoration of expression and activity by CHIP siRNA.

Canaff L, Vanbellinghen JF, Kanazawa I, Kwak H, Garfield N, Vautour L, Hendy GN.

J Clin Endocrinol Metab. 2012 Feb;97(2):E282-91. doi: 10.1210/jc.2011-0241. Epub 2011 Nov 16.

PubMed [citation]
PMID:
22090276

Developing effective screening strategies in multiple endocrine neoplasia type 1 (MEN 1) on the basis of clinical and sequencing data of German patients with MEN 1.

Schaaf L, Pickel J, Zinner K, Hering U, Höfler M, Goretzki PE, Spelsberg F, Raue F, von zur Mühlen A, Gerl H, Hensen J, Bartsch DK, Rothmund M, Schneyer U, Dralle H, Engelbach M, Karges W, Stalla GK, Höppner W.

Exp Clin Endocrinol Diabetes. 2007 Sep;115(8):509-17.

PubMed [citation]
PMID:
17853334
See all PubMed Citations (5)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV000541213.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (5)

Description

In summary, this variant is a rare missense that has been reported to disrupt protein function and has been reported in affected individuals. This evidence indicates that the variant is pathogenic, but additional data is needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Experimental studies have shown that this missense change disrupts protein stability in vitro (PMID: 22090276). This variant has been reported individuals affected with multiple endocrine neoplasia type 1 (MEN1) (PMID: 17853334, 25309600, 21069576). ClinVar contains an entry for this variant (Variation ID: 403825). This variant is not present in population databases (ExAC no frequency). This sequence change replaces serine with tyrosine at codon 443 of the MEN1 protein (p.Ser443Tyr). The serine residue is moderately conserved and there is a large physicochemical difference between serine and tyrosine.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024